[EN] N- CYCLOPROPYL - N- PIPERIDINYLBENZAMIDES AS GPR119 MODULATORS<br/>[FR] N-CYCLOPROPYL-N-PIPÉRIDINYLBENZAMIDES EN TANT QUE MODULATEURS DE GPR119
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2012123449A1
公开(公告)日:2012-09-20
The present invention relates to compounds of general formula I, wherein the groups R1, LP, LQ, Ar, mand n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.
New compounds, pharmaceutical compositions and uses thereof
申请人:NOSSE Bernd
公开号:US20130065906A1
公开(公告)日:2013-03-14
The present invention relates to compounds of general formula I,
wherein the groups R
1
, L
P
, L
Q
, Ar, m and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.
本发明涉及一般式I的化合物,
其中基团R
1
,L
P
,L
Q
,Ar,m和n如申请中所定义,具有有价值的药理特性,特别是结合GPR119受体并调节其活性。
Tetrazole Derivatives. III. Tetrazole Acid Derivatives
作者:R. A. LaFORGE、A. D'ADAMO、C. E. COSGROVE、C. R. JACOBSON
DOI:10.1021/jo01113a013
日期:1956.7
Bioisosteric replacement of 1H-1,2,3-triazole with 1H-tetrazole ring enhances anti-leukemic activity of (5-benzylthiazol-2-yl)benzamides